List of molecules and drugs that target protein P41595

#	DrugDomain Data	DrugBank Accession	Name	Drug action	Affinity data	InChI Key	SMILES
1	P41595_DB00247	DB00247	Methysergide	antagonist		KPJZHOPZRAFDTN-NQUBZZJWSA-N	[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
2	P41595_DB00248	DB00248	Cabergoline	agonist	Ki(nM) = 1.4 EC50(nM) = 13.0	KORNTPPJEAJQIU-KJXAQDMKSA-N	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
3	P41595_DB00315	DB00315	Zolmitriptan	agonist		ULSDMUVEXKOYBU-ZDUSSCGKSA-N	CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12
4	P41595_DB00320	DB00320	Dihydroergotamine	agonist		LUZRJRNZXALNLM-JGRZULCMSA-N	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
5	P41595_DB00353	DB00353	Methylergometrine	n/a	Ki(nM) = 0.49	UNBRKDKAWYKMIV-QWQRMKEZSA-N	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
6	P41595_DB00434	DB00434	Cyproheptadine	antagonist	Ki(nM) = 1.54	JJCFRYNCJDLXIK-UHFFFAOYSA-N	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
7	P41595_DB00508	DB00508	Triflupromazine	antagonist		XSCGXQMFQXDFCW-UHFFFAOYSA-N	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
8	P41595_DB00543	DB00543	Amoxapine	antagonist		QWGDMFLQWFTERH-UHFFFAOYSA-N	ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
9	P41595_DB00574	DB00574	Fenfluramine	agonist	Ki(nM) = 400.0	DBGIVFWFUFKIQN-UHFFFAOYSA-N	CCNC(C)CC1=CC=CC(=C1)C(F)(F)F
10	P41595_DB00589	DB00589	Lisuride	antagonist		BKRGVLQUQGGVSM-KBXCAEBGSA-N	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
11	P41595_DB00696	DB00696	Ergotamine	n/a	Ki(nM) = 3.0	XCGSFFUVFURLIX-VFGNJEKYSA-N	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
12	P41595_DB00714	DB00714	Apomorphine	agonist	Ki(nM) = 131.83	VMWNQDUVQKEIOC-CYBMUJFWSA-N	[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
13	P41595_DB00715	DB00715	Paroxetine	agonist	Ki(nM) = 10000.0	AHOUBRCZNHFOSL-YOEHRIQHSA-N	FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
14	P41595_DB00805	DB00805	Minaprine	antagonist		LDMWSLGGVTVJPG-UHFFFAOYSA-N	CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
15	P41595_DB00924	DB00924	Cyclobenzaprine	antagonist		JURKNVYFZMSNLP-UHFFFAOYSA-N	CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12
16	P41595_DB01079	DB01079	Tegaserod	antagonist		IKBKZGMPCYNSLU-RGVLZGJSSA-N	CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
17	P41595_DB01142	DB01142	Doxepin	antagonist		ODQWQRRAPPTVAG-UHFFFAOYSA-N	[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
18	P41595_DB01186	DB01186	Pergolide	agonist	Ki(nM) = 7.08	YEHCICAEULNIGD-MZMPZRCHSA-N	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
19	P41595_DB01200	DB01200	Bromocriptine	agonist	Ki(nM) = 56.23	OZVBMTJYIDMWIL-AYFBDAFISA-N	[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
20	P41595_DB01238	DB01238	Aripiprazole	inverse agonist	Ki(nM) = 0.36	CEUORZQYGODEFX-UHFFFAOYSA-N	ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
21	P41595_DB01242	DB01242	Clomipramine	antagonist		GDLIGKIOYRNHDA-UHFFFAOYSA-N	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2
22	P41595_DB01392	DB01392	Yohimbine	antagonist	Ki(nM) = 4.12	BLGXFZZNTVWLAY-SCYLSFHTSA-N	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
23	P41595_DB01454	DB01454	Midomafetamine	agonist	Ki(nM) = 500.0	SHXWCVYOXRDMCX-UHFFFAOYSA-N	CNC(C)CC1=CC2=C(OCO2)C=C1
24	P41595_DB04829	DB04829	Lysergic acid diethylamide	agonist	Ki(nM) = 8.91	VAYOSLLFUXYJDT-RDTXWAMCSA-N	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC
25	P41595_DB05461	DB05461	OPC-28326	n/a		QRNMKZJPTYRAIL-UHFFFAOYSA-N	O.Cl.CCC(=O)NC1=C(C)C=C(C=C1C)C(=O)N1CCC(CC1)N(C)CCC1=CC=CC=C1
26	P41595_DB05492	DB05492	Epicept NP-1	n/a		FKZUPMCBVURANR-UHFFFAOYSA-N	CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
27	P41595_DB05607	DB05607	PRX-08066	antagonist		RPYIKXHIQXRXEM-WLHGVMLRSA-N	OC(=O)\C=C\C(O)=O.FC1=C(C=C(CN2CCC(CC2)NC2=C3C=C(Cl)SC3=NC=N2)C=C1)C#N
28	P41595_DB06016	DB06016	Cariprazine	antagonist		KPWSJANDNDDRMB-QAQDUYKDSA-N	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
29	P41595_DB06148	DB06148	Mianserin	binder		UEQUQVLFIPOEMF-UHFFFAOYSA-N	CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
30	P41595_DB06153	DB06153	Pizotifen	antagonist		FIADGNVRKBPQEU-UHFFFAOYSA-N	CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
31	P41595_DB06216	DB06216	Asenapine	antagonist		VSWBSWWIRNCQIJ-UHFFFAOYSA-N	CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1
32	P41595_DB06229	DB06229	Ocaperidone	n/a		ZZQNEJILGNNOEP-UHFFFAOYSA-N	CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
33	P41595_DB09185	DB09185	Viloxazine	antagonist		YWPHCCPCQOJSGZ-UHFFFAOYSA-N	CCOC1=CC=CC=C1OCC1CNCCO1
34	P41595_DB09286	DB09286	Pipamperone	n/a	Ki(nM) = 47.4	AXKPFOAXAHJUAG-UHFFFAOYSA-N	NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1